Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Barclay ML"" wg kryterium: Autor


Tytuł:
Timing of Live Attenuated Vaccination in Infants Exposed to Infliximab or Adalimumab in Utero: A Prospective Cohort Study in 107 Children.
Autorzy:
Liu Z; Clinical Pharmacology, School of Medicine and Public Health, University of Newcastle, Hunter Medical Research Institute, Kookaburra Circuit, Australia.; Clinical Pharmacology, Department of Medicine, The Royal Children's Hospital Melbourne, Australia.; Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.
Julsgaard M; Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.; Institute of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Department of Gastroenterology, St Vincent's Hospital, and University of Melbourne, Melbourne, Australia.
Zhu X; Department of Clinical Pharmacy and Pharmacy Administration, School of Pharmacy, Fudan University, China.; School of Pharmacy, University of Otago, Dunedin, New Zealand.
Martin J; Clinical Pharmacology, School of Medicine and Public Health, University of Newcastle, Hunter Medical Research Institute, Kookaburra Circuit, Australia.
Barclay ML; Departments of Gastroenterology & Clinical Pharmacology, Christchurch Hospital, Christchurch, New Zealand.
Cranswick N; Clinical Pharmacology, Department of Medicine, The Royal Children's Hospital Melbourne, Australia.
Gibson PR; Department of Gastroenterology, Alfred Hospital, and Monash University, Melbourne, VIC, Australia.
Gearry RB; Department of Medicine, University of Otago, Christchurch, New Zealand.
van der Giessen J; Department of Gastroenterology and Hepatology, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.
Connor SJ; Department of Gastroenterology, Liverpool Hospital, Sydney.; South Western Sydney Clinical, University of NSW Sydney.; Ingham Institute of Applied Medical Research, Sydney, Australia.
Rosella O; Department of Gastroenterology, Alfred Hospital, and Monash University, Melbourne, VIC, Australia.
Grosen A; Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.
Toong C; South Western Sydney Clinical, University of NSW Sydney.; Sydney South West Pathology Service, Liverpool Hospital, University of NSW, Sydney, Australia.
Flanagan E; Department of Gastroenterology, St Vincent's Hospital, and University of Melbourne, Melbourne, Australia.
Wieringa JW; Department of Pediatrics, Haaglanden Medical Center, the Hague, The Netherlands.; Department of Pediatrics, Division of Paediatric Infectious Diseases and Immunology, Erasmus MC University Medical Centre-Sophia Children's Hospital, Rotterdam, The Netherlands.
Janneke van der Woude C; Department of Gastroenterology and Hepatology, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.
Bell SJ; Department of Gastroenterology, St Vincent's Hospital, and University of Melbourne, Melbourne, Australia.; Department of Gastroenterology, Monash Health, and School of Clinical Sciences Monash University, Melbourne, VIC, Australia.
Pokaż więcej
Corporate Authors:
CARINA Study Group
Źródło:
Journal of Crohn's & colitis [J Crohns Colitis] 2022 Dec 05; Vol. 16 (12), pp. 1835-1844.
Typ publikacji:
Journal Article
MeSH Terms:
Adalimumab*/therapeutic use
Inflammatory Bowel Diseases*/drug therapy
Infliximab*/therapeutic use
Vaccines, Attenuated*/administration & dosage
Child ; Female ; Humans ; Infant ; Infant, Newborn ; Pregnancy ; Bayes Theorem ; Prospective Studies ; Tumor Necrosis Factor Inhibitors/therapeutic use ; Vaccination ; Maternal Exposure
Czasopismo naukowe
Tytuł:
Systematic review with meta-analysis: SARS-CoV-2 stool testing and the potential for faecal-oral transmission.
Autorzy:
van Doorn AS; Departments of Gastroenterology & Clinical Pharmacology, Christchurch Hospital, Canterbury District Health Board and University of Otago, Christchurch, New Zealand.; Department of Gastroenterology and Hepatology, AG&M Research Institute, Amsterdam University Medical Centre, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
Meijer B; Department of Gastroenterology and Hepatology, AG&M Research Institute, Amsterdam University Medical Centre, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.; Department of Gastroenterology and Hepatology, Noordwest Ziekenhuisgroep Alkmaar, the Netherlands.
Frampton CMA; Department of Biostatistics & Medicine, Christchurch Hospital, Canterbury District Health Board and University of Otago, Christchurch, New Zealand.
Barclay ML; Departments of Gastroenterology & Clinical Pharmacology, Christchurch Hospital, Canterbury District Health Board and University of Otago, Christchurch, New Zealand.
de Boer NKH; Department of Gastroenterology and Hepatology, AG&M Research Institute, Amsterdam University Medical Centre, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2020 Oct; Vol. 52 (8), pp. 1276-1288. Date of Electronic Publication: 2020 Aug 27.
Typ publikacji:
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms:
Coronavirus Infections/*pathology
Feces/*virology
Pneumonia, Viral/*pathology
Virus Shedding/*physiology
Adult ; Betacoronavirus ; COVID-19 ; Gastrointestinal Tract/virology ; Humans ; Pandemics ; SARS-CoV-2
Czasopismo naukowe
Tytuł:
Thiopurines in Inflammatory Bowel Disease: New Findings and Perspectives.
Autorzy:
de Boer NKH; Department of Gastroenterology and Hepatology, VU University Medical Centre, Amsterdam, The Netherlands.
Peyrin-Biroulet L; Department of Gastroenterology and Hepatology and Inserm U954, Nancy University Hospital, Lorraine University, Vandoeuvre-lès-Nancy, France.
Jharap B; Department of Gastroenterology, Meander Medical Centre, Amersfoort, The Netherlands.
Sanderson JD; Department of Gastroenterology, Guy's and St Thomas' Hospitals, London, UK.
Meijer B; Department of Gastroenterology and Hepatology, VU University Medical Centre, Amsterdam, The Netherlands.
Atreya I; Department of Gastroenterology, Pneumology and Endocrinology, Universitätsklinikum Erlangen, University of Erlangen-Nürnberg, Germany.
Barclay ML; Department of Gastroenterology, Christchurch Hospital, Christchurch, New Zealand.
Colombel JF; Department of Gastroenterology, Mount Sinai Hospital, New York, NY, USA.
Lopez A; Department of Gastroenterology and Hepatology and Inserm U954, Nancy University Hospital, Lorraine University, Vandoeuvre-lès-Nancy, France.
Beaugerie L; Department of Gastroenterology, AP-HP, Hôpital Saint-Antoine,UPMC University, Paris, France.
Marinaki AM; Purine Research Laboratory, Guy's and St Thomas' Hospitals, London, UK.
van Bodegraven AA; Department of Gastroenterology and Hepatology, VU University Medical Centre, Amsterdam, The Netherlands.; Department of Gastroenterology, Geriatrics, Internal and Intensive Care Medicine [Co-MIK], Zuyderland Medical Centre, Heerlen-Sittard-Geleen, The Netherlands.
Neurath MF; Department of Gastroenterology, Pneumology and Endocrinology, Universitätsklinikum Erlangen, University of Erlangen-Nürnberg, Germany.
Pokaż więcej
Źródło:
Journal of Crohn's & colitis [J Crohns Colitis] 2018 Apr 27; Vol. 12 (5), pp. 610-620.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Azathioprine/*therapeutic use
Immunosuppressive Agents/*therapeutic use
Inflammatory Bowel Diseases/*drug therapy
Mercaptopurine/*therapeutic use
Neoplasms/*epidemiology
Thioguanine/*therapeutic use
Azathioprine/pharmacology ; Drug Therapy, Combination ; Gastrointestinal Agents/therapeutic use ; Humans ; Immunosuppressive Agents/pharmacology ; Infliximab/therapeutic use ; Mercaptopurine/pharmacology ; Risk Factors ; Thioguanine/pharmacology
Czasopismo naukowe
Tytuł:
Randomised clinical trial: efficacy, safety and dosage of adjunctive allopurinol in azathioprine/mercaptopurine nonresponders (AAA Study).
Autorzy:
Friedman AB; Department of Gastroenterology, The Alfred Hospital and Monash University, Melbourne, Australia.
Brown SJ; St Vincent's Hospital, Melbourne, Australia.
Bampton P; Flinders medical Centre, Adelaide, Australia.
Barclay ML; Christchurch Hospital, Christchurch, New Zealand.
Chung A; Eastern Health and Monash University, Melbourne, Australia.
Macrae FA; Royal Melbourne Hospital, Melbourne, Australia.
McKenzie J; The Alfred Hospital and Monash University, Melbourne, Australia.
Reynolds J; The Alfred Hospital and Monash University, Melbourne, Australia.
Gibson PR; The Alfred Hospital and Monash University, Melbourne, Australia.
Hanauer SB; Northwestern University, Chicago, USA.
Sparrow MP; The Alfred Hospital and Monash University, Melbourne, Australia.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2018 Apr; Vol. 47 (8), pp. 1092-1102. Date of Electronic Publication: 2018 Feb 21.
Typ publikacji:
Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms:
Allopurinol/*therapeutic use
Azathioprine/*therapeutic use
Immunosuppressive Agents/*therapeutic use
Inflammatory Bowel Diseases/*drug therapy
Mercaptopurine/*therapeutic use
Adolescent ; Adult ; Double-Blind Method ; Drug Therapy, Combination ; Female ; Humans ; Male ; Middle Aged ; Treatment Outcome ; Young Adult
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies